DC Chemicals

All products / DC48219

Safusidenib
CAT. NO. DC48219

Safusidenib

Pack sizes and prices

Pack sizePrice
100mg$550 USDRequest a quote / confirm availability →
250mg$900 USDRequest a quote / confirm availability →
1g$1,800 USDRequest a quote / confirm availability →

Confirm stock, lead time, shipping and final quotation with our team.

Product overview

Safusidenib (AB-291; DS-1001) is an orally bioavailable, selective mutant IDH1 inhibitor. Safusidenib strongly inhibits mutant IDH1 but not wild-type IDH1. Safusidenib impairs tumor activity in chondrosarcoma. Safusidenib exhibits activity against IDH1R132H, and IDH1R132C with IC50s of 15, and 130 nM in assays without any preincubation, respectively.

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC48219
Product nameSafusidenib
CAS1898206-17-1
Molecular formulaC25H18Cl3FN2O4
Molecular weight535.778827190399
Purity98%
SMILESCc1cn(C(=O)c2c(-c3c(Cl)cc(Cl)cc3Cl)noc2C(C)(C)F)c2cccc(/C=C/C(=O)O)c12

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — Safusidenib (DC48219)

Related research products

Browse newly added products